Alebund Pharmaceuticals is a biopharmaceutical company dedicated to developing innovative therapies for the treatment of renal diseases. Founded by Gavin Xia and Jin Tian in 2018Alebund Pharmaceuticals is backed by Lilly Asia Ventures, Quan Capital, Loyal Valley Capital, Sherpa Venture Capital, and Verition Fund Management and is headquartered in Shanghai.